Literature DB >> 10193682

Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis?

J R O'Dell1.   

Abstract

Despite many advances in the understanding and treatment of rheumatoid arthritis, its pathophysiology remains incompletely understood. An infectious aetiology of rheumatoid arthritis has long been postulated but, even though many continue to believe that there is a 'triggering agent for rheumatoid arthritis', none has been identified. Currently, both sulfasalazine and minocycline have been shown to be effective treatments for rheumatoid arthritis and are being used increasingly. In the case of minocycline, it appears that its ability to inhibit metalloproteases is an important characteristic that may account for some or part of its action against rheumatoid arthritis. Whether the antibacterial effects of these drugs or others are important in the treatment of rheumatoid arthritis continues to be investigated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193682     DOI: 10.2165/00003495-199957030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  33 in total

1.  Doxycycline inhibits type XI collagenolytic activity of extracts from human osteoarthritic cartilage and of gelatinase.

Authors:  L P Yu; G N Smith; K A Hasty; K D Brandt
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

2.  Tetracycline in the treatment of rheumatoid arthritis. A double blind controlled study.

Authors:  M Skinner; E S Cathcart; J A Mills; R S Pinals
Journal:  Arthritis Rheum       Date:  1971 Nov-Dec

3.  Tetracyclines inhibit human synovial collagenase in vivo and in vitro.

Authors:  R A Greenwald; L M Golub; B Lavietes; N S Ramamurthy; B Gruber; R S Laskin; T F McNamara
Journal:  J Rheumatol       Date:  1987-02       Impact factor: 4.666

4.  Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.

Authors:  J R O'Dell; C E Haire; W Palmer; W Drymalski; S Wees; K Blakely; M Churchill; P J Eckhoff; A Weaver; D Doud; N Erikson; F Dietz; R Olson; P Maloley; L W Klassen; G F Moore
Journal:  Arthritis Rheum       Date:  1997-05

5.  Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.

Authors:  I Caruso; F Montrone; M Fumagalli; C Patrono; S Santandrea; M C Gandini
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

6.  Sequential study of bacterial antibody levels and faecal flora in rheumatoid arthritis patients taking sulphasalazine.

Authors:  S M Bradley; V C Neumann; K Barr; P R Troughton; C Astbury; H A Bird; H C Gooi; V Wright
Journal:  Br J Rheumatol       Date:  1993-08

7.  The effects of minocycline and tetracycline on the mitotic response of human peripheral blood-lymphocytes.

Authors:  E Ingham; L Turnbull; J N Kearney
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

8.  Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

Authors:  V C Neumann; K A Grindulis; S Hubball; B McConkey; V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

9.  The role of the MA-sensitive leukocyte chemotaxis in rheumatoid arthritis. A randomized double-blind clinical trial of griseofulvin treatment.

Authors:  F Nilsson; B Norberg; B Frederiksen; S Eriksson
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

Review 10.  Dapsone in rheumatoid arthritis.

Authors:  D J Chang; M Lamothe; R M Stevens; L H Sigal
Journal:  Semin Arthritis Rheum       Date:  1996-06       Impact factor: 5.532

View more
  4 in total

1.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window.

Authors:  J Yrjänheikki; T Tikka; R Keinänen; G Goldsteins; P H Chan; J Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

3.  Delayed minocycline but not delayed mild hypothermia protects against embolic stroke.

Authors:  Chen Xu Wang; Tao Yang; Raza Noor; Ashfaq Shuaib
Journal:  BMC Neurol       Date:  2002-04-18       Impact factor: 2.474

Review 4.  Matrix metalloproteinases in arthritic disease.

Authors:  Gillian Murphy; Vera Knäuper; Susan Atkinson; George Butler; William English; Mike Hutton; Jan Stracke; Ian Clark
Journal:  Arthritis Res       Date:  2002-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.